Wei Zhao
Memorial Sloan Kettering Cancer Center(US)Nanchang University(CN)Qingdao University of Science and Technology(CN)Shandong University(CN)Harbin Medical University(CN)Sun Yat-sen University(CN)Bengbu Medical College(CN)Dalian Medical University(CN)Anhui Medical University(CN)Nantong University(CN)University of Michigan(US)Chinese PLA General Hospital(CN)Affiliated Hospital of Nantong University(CN)Second Affiliated Hospital of Chongqing Medical University(CN)Shanghai University of Traditional Chinese Medicine(CN)Longhua Hospital Shanghai University of Traditional Chinese Medicine(CN)Nanfang Hospital(CN)Shandong Provincial Hospital(CN)First Affiliated Hospital of Xi'an Jiaotong University(CN)Bethune International Peace Hospital(CN)Stomatology Hospital(CN)University of Hong Kong - Shenzhen Hospital(CN)Guangdong Academy of Medical Sciences(CN)Guangdong Provincial People's Hospital(CN)Shandong First Medical University(CN)Southern Medical University(CN)Chongqing Medical University(CN)University of Hong Kong(HK)
Publications by Year
Research Areas
interferon and immune responses, Inflammasome and immune disorders, Immune Response and Inflammation, Ubiquitin and proteasome pathways, NF-κB Signaling Pathways
Most-Cited Works
- → NLRP3 Inflammasome—A Key Player in Antiviral Responses(2020)427 cited
- → The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3(2016)414 cited
- → Redox homeostasis maintained by GPX4 facilitates STING activation(2020)389 cited
- BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.(2003)
- → Remote Light‐Responsive Nanocarriers for Controlled Drug Delivery: Advances and Perspectives(2019)310 cited
- → Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression(2013)295 cited
- → Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1(2008)